SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Merck
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
1580 80 0 MRK
Emcee:  Alfred W. Post Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1480wsj: Study Raises Questions On Short-Term Vioxx Use By ELENA CHERNEY and HEATHEmopgcw-5/3/2006
1479Citi: MRK: 1Q06 EPS Broadly In-Line; Raises FY06 Guidance HOLD (2) Mediumopgcw-4/25/2006
1478Citi: MRK: EPS PREP PACK, 1Q 2006 HOLD (2) Medium Risk (M) Mkt Cap: $mopgcw-4/25/2006
1477Citi: MRK: Loses Garza TX Trial HOLD (2) Medium Risk (M) Mkt Cap: $7mopgcw-4/25/2006
1476Citi: MRK: NJ VIOXX VERDICTS MODESTLY NEGATIVE HOLD (2) Medium Riskmopgcw-4/8/2006
1475Vioxx Jury Holds Merck Liable for Heart Attack [WSJ] Split Verdict Awards One ODoc Bones-4/6/2006
1474See any after market reaction to this news?Paul Chiu-4/1/2006
1473Court Upholds Vioxx Class Action Stakes Rise in Merck Suit As Health-Care Plan mopgcw-4/1/2006
1472[WSJ Snippet] Meanwhile, Merck is expected to announce a deal with closely heldDoc Bones-3/20/2006
1471AZN may be compelled to buy out Merck's royaly rights for several billion (Snigel bates-3/13/2006
1470Merck Says Vytorin Does Well in Studies... By TSC Staff 3/13/2006 7:50 AM EST William F. Wager, Jr.-3/13/2006
1469wsj:Vioxx Doctors Wooed by Merck Are Now Its Foes By HEATHER WON TESORIERO Marmopgcw-3/10/2006
1468Interesting. Thanks!keokalani'nui-3/6/2006
1467Citigroup : MRK: VIOXX LIABILITY HIGHLY MANAGEABLE; KEY PANEL TAKEAWAYS HOLmopgcw-3/6/2006
1466gs; MRK (U/N): Januvia NDA acceptance a surprise 52-Week Range US$35-26 YTD Primopgcw-3/6/2006
1465gs: MRK (U/N): Key takeaways from ACIP meeting on Gardasil 52-Week Range US$36-mopgcw-3/6/2006
1464merck is a bit of a gamble on jurieshdl-3/2/2006
1463Citigroup MRK: Solid 4Q05 EPS January 31, 2006 HOLD (2) Medium Riskmopgcw-2/27/2006
1462Citigroup MRK: Prevails in First Federal Court Case February 20,mopgcw-2/27/2006
1461AP: Journal Editors Dispute Merck Claim Friday February 10, 5:29 am ET By TherDoc Bones-2/10/2006
1460Merck Posts 1.7% Profit Rise, Reserves More Funds for Vioxx By PETER LOFTUS StDoc Bones-1/31/2006
1459Fred, Three more quick search results at the bottom and an excerpt from The MerRampex-1/28/2006
1458Fred, Thanks for your good wishes. I will try to find some more specific citatiRampex-1/28/2006
1457Rampex: Elan is by far my largest position. I would go on T if I had MS, too. Afred hayes-1/27/2006
1456Will Acquisitions Patch Merck's Pipeline? By Rich Duprey (TMF Cop) January mopgcw-1/27/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News